Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 78

1.

Treatment-induced stable, moderate reduction in blood cell counts correlate to disease control in early rheumatoid arthritis.

Lester SE, Proudman SM, Lee AT, Hall CA, McWilliams L, James MJ, Cleland LG.

Intern Med J. 2009 May;39(5):296-303. doi: 10.1111/j.1445-5994.2008.01737.x. Epub 2008 Jun 28.

PMID:
19371393
[PubMed - indexed for MEDLINE]
2.

Response-driven combination therapy with conventional disease-modifying antirheumatic drugs can achieve high response rates in early rheumatoid arthritis with minimal glucocorticoid and nonsteroidal anti-inflammatory drug use.

Proudman SM, Keen HI, Stamp LK, Lee AT, Goldblatt F, Ayres OC, Rischmueller M, James MJ, Hill CL, Caughey GE, Cleland LG.

Semin Arthritis Rheum. 2007 Oct;37(2):99-111. Epub 2007 Mar 27.

PMID:
17391739
[PubMed - indexed for MEDLINE]
3.

Contemporary use of disease-modifying drugs in the management of patients with early rheumatoid arthritis in Norway.

Nikolaisen C, Kvien TK, Mikkelsen K, Kaufmann C, Rødevand E, Nossent JC.

Scand J Rheumatol. 2009;38(4):240-5. doi: 10.1080/03009740802609566.

PMID:
19229766
[PubMed - indexed for MEDLINE]
4.

Infliximab treatment for rheumatoid arthritis, with dose titration based on the Disease Activity Score: dose adjustments are common but not always sufficient to assure sustained benefit.

Sidiropoulos P, Bertsias G, Kritikos HD, Kouroumali H, Voudouris K, Boumpas DT.

Ann Rheum Dis. 2004 Feb;63(2):144-8.

PMID:
14722202
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Leflunomide treatment in elderly patients with rheumatoid or psoriatic arthritis: retrospective analysis of safety and adherence to treatment.

Alivernini S, Mazzotta D, Zoli A, Ferraccioli G.

Drugs Aging. 2009;26(5):395-402. doi: 10.2165/00002512-200926050-00003.

PMID:
19552491
[PubMed - indexed for MEDLINE]
6.

Plasma adiponectin in patients with active, early, and chronic rheumatoid arthritis who are steroid- and disease-modifying antirheumatic drug-naive compared with patients with osteoarthritis and controls.

Laurberg TB, Frystyk J, Ellingsen T, Hansen IT, Jørgensen A, Tarp U, Hetland ML, Hørslev-Petersen K, Hornung N, Poulsen JH, Flyvbjerg A, Stengaard-Pedersen K.

J Rheumatol. 2009 Sep;36(9):1885-91. doi: 10.3899/jrheum.080907. Epub 2009 Aug 14.

PMID:
19684150
[PubMed - indexed for MEDLINE]
7.

[Leflunomide as a second choice treatment in patients with rheumatoid arthritis].

Raczkiewicz-Papierska A, Dudek A, Bachta A, Tłustochowicz M, Zawadyl B, Sułek M.

Pol Merkur Lekarski. 2007 Jun;22(132):547-50. Polish.

PMID:
17874627
[PubMed - indexed for MEDLINE]
8.

Influence of glucocorticoids and disease activity on total and high density lipoprotein cholesterol in patients with rheumatoid arthritis.

Boers M, Nurmohamed MT, Doelman CJ, Lard LR, Verhoeven AC, Voskuyl AE, Huizinga TW, van de Stadt RJ, Dijkmans BA, van der Linden S.

Ann Rheum Dis. 2003 Sep;62(9):842-5.

PMID:
12922956
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.

Hyrich KL, Watson KD, Silman AJ, Symmons DP; British Society for Rheumatology Biologics Register.

Rheumatology (Oxford). 2006 Dec;45(12):1558-65. Epub 2006 May 16.

PMID:
16705046
[PubMed - indexed for MEDLINE]
Free Article
10.

Tight control and intensified COBRA combination treatment in early rheumatoid arthritis: 90% remission in a pilot trial.

van Tuyl LH, Lems WF, Voskuyl AE, Kerstens PJ, Garnero P, Dijkmans BA, Boers M.

Ann Rheum Dis. 2008 Nov;67(11):1574-7. doi: 10.1136/ard.2008.090712. Epub 2008 Jul 14.

PMID:
18625629
[PubMed - indexed for MEDLINE]
11.

Titration of infliximab treatment in rheumatoid arthritis patients based on response patterns.

Flendrie M, Creemers MC, van Riel PL.

Rheumatology (Oxford). 2007 Jan;46(1):146-9. Epub 2006 Jun 16.

PMID:
16782732
[PubMed - indexed for MEDLINE]
Free Article
12.
13.

Potential novel biomarkers of disease activity in rheumatoid arthritis patients: CXCL13, CCL23, transforming growth factor alpha, tumor necrosis factor receptor superfamily member 9, and macrophage colony-stimulating factor.

Rioja I, Hughes FJ, Sharp CH, Warnock LC, Montgomery DS, Akil M, Wilson AG, Binks MH, Dickson MC.

Arthritis Rheum. 2008 Aug;58(8):2257-67. doi: 10.1002/art.23667.

PMID:
18668547
[PubMed - indexed for MEDLINE]
Free Article
14.

Does active treatment of rheumatoid arthritis limit disease-associated bone loss?

Dolan AL, Moniz C, Abraha H, Pitt P.

Rheumatology (Oxford). 2002 Sep;41(9):1047-51.

PMID:
12209040
[PubMed - indexed for MEDLINE]
Free Article
15.

Treatment of early seropositive rheumatoid arthritis: doxycycline plus methotrexate versus methotrexate alone.

O'Dell JR, Elliott JR, Mallek JA, Mikuls TR, Weaver CA, Glickstein S, Blakely KM, Hausch R, Leff RD.

Arthritis Rheum. 2006 Feb;54(2):621-7.

PMID:
16447240
[PubMed - indexed for MEDLINE]
Free Article
16.

Number of active joints, not diagnosis, is the primary determinant of function and performance in early synovitis.

Gerber LH, Furst G, Yarboro C, el-Gabalawy H.

Clin Exp Rheumatol. 2003 Sep-Oct;21(5 Suppl 31):S65-70.

PMID:
14969053
[PubMed - indexed for MEDLINE]
17.

Aggressive combination therapy with intra-articular glucocorticoid injections and conventional disease-modifying anti-rheumatic drugs in early rheumatoid arthritis: second-year clinical and radiographic results from the CIMESTRA study.

Hetland ML, Stengaard-Pedersen K, Junker P, Lottenburger T, Hansen I, Andersen LS, Tarp U, Svendsen A, Pedersen JK, Skjødt H, Lauridsen UB, Ellingsen T, Hansen GV, Lindegaard H, Vestergaard A, Jurik AG, Østergaard M, Hørslev-Petersen K; CIMESTRA study group.

Ann Rheum Dis. 2008 Jun;67(6):815-22. Epub 2007 Sep 18.

PMID:
17878209
[PubMed - indexed for MEDLINE]
18.

Concentrations of BAFF correlate with autoantibody levels, clinical disease activity, and response to treatment in early rheumatoid arthritis.

Bosello S, Youinou P, Daridon C, Tolusso B, Bendaoud B, Pietrapertosa D, Morelli A, Ferraccioli G.

J Rheumatol. 2008 Jul;35(7):1256-64.

PMID:
18528969
[PubMed - indexed for MEDLINE]
19.

Rituximab therapy in patients with rheumatoid arthritis refractory or with contraindication to anti-tumour necrosis factor drugs: real-life experience in Finnish patients.

Valleala H, Korpela M, Möttönen T, Hienonen-Kempas T, Kauppi M, Hannonen P, Leirisalo-Repo M.

Scand J Rheumatol. 2009;38(5):323-7. doi: 10.1080/03009740902946355.

PMID:
19585384
[PubMed - indexed for MEDLINE]
20.

Triple therapy in early active rheumatoid arthritis: a randomized, single-blind, controlled trial comparing step-up and parallel treatment strategies.

Saunders SA, Capell HA, Stirling A, Vallance R, Kincaid W, McMahon AD, Porter DR.

Arthritis Rheum. 2008 May;58(5):1310-7. doi: 10.1002/art.23449.

PMID:
18438851
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk